Novo Nordisk Investors
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Founded Date:
1923
Technology:
Biotechnology, Health Care, Science and Engineering
Investor Type:
Undisclosed
Funding Status:
IPO
Total Funding:
22000000
Employee Number:
10001+
Headquarters:
Bagsværd, Hovedstaden, Denmark
Last Funding Date:
2018-12-05 00:00:00
Investors Number:
14
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$1B to $10B
Investment Stage:
N/A
Acquisitions Number:
8.0
Number Of Exists:
4
Industry:
End-to-End Drug Development